Literature DB >> 35306549

Romanian Guidelines for the Diagnosis and Treatment of GERD-induced Respiratory Manifestations.

Vasile Liviu Drug1, Sabina Antoniu2, Barboi Bogdana Oana3, Oana Cristina Arghir4, Ion Bancila5, Simona Bataga6, Ciprian Brisc7, Cristina Cijevschi-Prelipcean8, Mihai Ciocîrlan9, Irina Ciortescu10, Liliana David11, Oana Claudia Deleanu12, Mircea Diculescu13, Anca Dimitriu14, Daniela Dobru15, Eugen Dumitru16, Dan Ionut Gheonea17, Cristian Gheorghe18, Adrian Goldis19, Mariana Jinga20, Milena Man21, Bogdan Mateescu22, Mircea Manuc23, Catalina Mihai24, Florin Mihaltan25, Traian Mihaescu26, Laurentiu Nedelcu27, Lucian Negreanu28, Carmen Monica Pop29, Ruxandra Rajnoveanu30, Adrian Saftoiu31, Andrada Seicean32, Ioan Sporea33, Carol Stanciu34, Teodora Surdea-Blaga35, Marcel Tantau36, Doina Todea37, Anca Victorita Trifan38, Ruxandra Ulmeanu39, Diana Elena Iov40, Dan Lucian Dumitrascu41.   

Abstract

BACKGROUND AND AIMS: Gastroesophageal reflux disease (GERD) is a common condition present in daily practice with a wide range of clinical phenotypes. In this line, respiratory conditions may be associated with GERD. The Romanian Societies of Gastroenterology and Neurogastroenterology, in association with the Romanian Society of Pneumology, aimed to create a guideline regarding the epidemiology, diagnosis and treatment of respiratory conditions associated with GERD.
METHODS: Delphi methodology was used and eleven common working groups of experts were created. The experts reviewed the literature according to GRADE criteria and formulated 34 statements and recommendations. Consensus (>80% agreement) was reached for some of the statements after all participants voted.
RESULTS: All the statements and the literature review are presented in the paper, together with their correspondent grade of evidence and the voting results. Based on >80% voting agreement, a number of 22 recommendations were postulated regarding the diagnosis and treatment of GERD-induced respiratory symptoms. The experts considered that GERD may cause bronchial asthma and chronic cough in an important number of patients through micro-aspiration and vagal-mediated tracheobronchial reflex. GERD should be suspected in patients with asthma with suboptimal controlled or after exclusion of other causes, also in nocturnal refractory cough which needs gastroenterological investigations to confirm the diagnosis. Therapeutic test with double dose proton pump inhibitors (PPI) for 3 months is also useful. GERD induced respiratory conditions are difficult to treat; however,proton pump inhibitors and laparoscopic Nissen fundoplication are endorsed for therapy.
CONCLUSIONS: This guideline could be useful for the multidisciplinary management of GERD with respiratory symptoms in current practice.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35306549     DOI: 10.15403/jgld-4196

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  1 in total

1.  Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study.

Authors:  Tsung-Kun Lin; Chin-Feng Tsai; Jing-Yang Huang; Lung-Fa Pan; Gwo-Ping Jong
Journal:  J Pers Med       Date:  2022-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.